ly 274614 has been researched along with gyki 52466 in 1 studies
Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (gyki 52466) | Trials (gyki 52466) | Recent Studies (post-2010) (gyki 52466) |
---|---|---|---|---|---|
96 | 0 | 15 | 312 | 0 | 38 |
Protein | Taxonomy | ly 274614 (IC50) | gyki 52466 (IC50) |
---|---|---|---|
Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 10 | |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 10 | |
Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 10 | |
Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borowicz, K; Czuczwar, SJ; Gasior, M; Kleinrok, Z; Starownik, R | 1 |
1 other study(ies) available for ly 274614 and gyki 52466
Article | Year |
---|---|
Anticonvulsant and adverse effects of MK-801, LY 235959, and GYKI 52466 in combination with Ca2+ channel inhibitors in mice.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Avoidance Learning; Benzodiazepines; Calcium Channel Blockers; Dizocilpine Maleate; Drug Interactions; Electroshock; Excitatory Amino Acid Antagonists; Flunarizine; Isoquinolines; Male; Mice; Motor Activity; Nicardipine; Nifedipine; Seizures | 1997 |